Thomas J. Schall, a director at Immuneering Corp ($IMRX), made three open market purchases totaling about $225 thousand over the past year. His most recent buy occurred on January 15, 2026. These purchases rank him 1,441st among nearly 5,000 insiders, below the average buy amount of 1.5 million across 3.29 transactions per insider. Schall reported no open market sales in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 15, 2026 | Immuneering Corp | $IMRX | Schall Thomas J. | Director | P | Class A Common Stock | 21645 | $4.67 | 74,530.0000 | 64,569,967 | 40.93% | 0.03% |
| June 27, 2025 | Immuneering Corp | $IMRX | Schall Thomas J. | Director | P | Class A Common Stock | 9500 | $3.66 | 52,885.0000 | 35,887,252 | 21.90% | 0.03% |
| June 17, 2025 | Immuneering Corp | $IMRX | Schall Thomas J. | Director | P | Class A Common Stock | 40485 | $2.21 | 43,385.0000 | 35,887,252 | 1396.03% | 0.11% |
| June 13, 2025 | Immuneering Corp | $IMRX | Schall Thomas J. | Director | A | Stock Option | 33350 | $0.00 | 33,350.0000 | 35,887,252 | 9999.99% | 0.09% |
| June 12, 2024 | Immuneering Corp | $IMRX | Schall Thomas J. | Director | A | Stock Option | 8588 | $0.00 | 8,588.0000 | 0 | 9999.99% | 0.00% |
| March 22, 2024 | Immuneering Corp | $IMRX | Schall Thomas J. | Not found | P | Class A Common Stock | 2900 | $2.55 | 2,900.0000 | 0 | 9999.99% | 0.00% |
| March 11, 2024 | Immuneering Corp | $IMRX | Schall Thomas J. | Not found | A | Stock Option | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |